The University of Sydney has been recognised at the Australian Financial Review Higher Education Awards 2024, with Professor Michael Kassiou a joint winner for his research and work co-founding Kinoxis Therapeutics.
The Research Commercialisation category celebrates researchers working in partnership with industry to achieve real-world impacts. Professor Kassiou has pioneered research on drug discovery, leading to new treatment strategies for brain and cardiovascular disorders. He also received the 2023 Australian Museum Eureka Prize for Leadership in Science and Innovation and the 2023 HG Smith Memorial Award.
"This AFR Higher Education Award is a wonderful recognition of our work over many years,” Professor Kassiou said.
“The path from drug discovery to commercialisation is long but it is very rewarding to develop novel science that delivers direct human benefit. The work of my colleagues and research students has been both inspiring and invaluable, and I am grateful to Kinoxis Therapeutics for the opportunity to contribute to their ongoing commercial success."
